Abstract:RNA repeat expansions fold into stable structures and cause microsatellite diseases such as Huntington's disease (HD), myotonic dystrophy type 1 (DM1), and spinocerebellar ataxias (SCAs). The trinucleotide expansion of r(CAG), or r(CAG) exp , causes both HD and SCA3, and the RNA's toxicity has been traced to its translation into polyglutamine (polyQ; HD) as well as aberrant pre-mRNA alternative splicing (SCA3 and HD). Previously, a small molecule, 1 , was discovered that binds to r(CAG) exp and rescues aberrant pre-mRNA splicing in patient-derived fibroblasts by freeing proteins bound to the repeats. Here, we report the structures of single r(CAG) repeat motif (5'C A G/3'G A C where the underlined adenosines form a 1×1 nucleotide internal loop) in complex with 1 and two other small molecules via nuclear magnetic resonance (NMR) spectroscopy combined with simulated annealing. Compound 2 was designed based on the structure of 1 bound to the RNA while 3 was selected as a diverse chemical scaffold. The three complexes, although adopting different 3D binding pockets upon ligand binding, are stabilized by a combination of stacking interactions with the internal loop's closing GC base pairs, hydrogen bonds, and van der Waals interactions. Molecular dynamics (MD) simulations performed with NMR-derived restraints show that the RNA is stretched and bent upon ligand binding with significant changes in propeller-twist and opening. Compound 3 has a distinct mode of binding by insertion into the helix, displacing one of the loop nucleotides into the major groove and affording a rod-like shape binding pocket. In contrast, 1 and 2 are groove binders. A series of single molecule magnetic force spectroscopy studies provide a mechanistic explanation for how bioactive compounds might rescue disease-associated cellular phenotypes.

A crystal structure of a model of the repeating r(CGG) transcript found in fragile X syndrome.

Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/β-catenin pathway in C9ALS/FTD

Structural Studies Of The Tandem Tudor Domains Of Fragile X Mental Retardation Related Proteins Fxr1 And Fxr2

Crystallographic and Computational Analyses of Auucu Repeating Rna That Causes Spinocerebellar Ataxia Type 10 (Sca10)

Crystal structure of a tetrameric RNA G-quadruplex formed by hexanucleotide repeat expansions of C9orf72 in ALS/FTD

The molecular biology of FMRP: new insights into fragile X syndrome

The tetraplex (CGG)n destabilizing proteins hnRNP A2 and CBF-A enhance the in vivo translation of fragile X premutation mRNA

FXTAS: a bad RNA and a hope for a cure.

Epigenetic insights into Fragile X Syndrome

Mechanistic convergence across initiation sites for RAN translation in fragile X associated tremor ataxia syndrome

From wings to whiskers to stem cells: why every model matters in fragile X syndrome research

FMRP(1–297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome

The FMRpolyGlycine Protein Mediates Aggregate Formation and Toxicity Independent of the CGG mRNA Hairpin in a Cellular Model for FXTAS

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene

Mechanisms of Genome Instability in the Fragile X-Related Disorders

NMR structures and magnetic force spectroscopy studies of small molecules binding to models of an RNA CAG repeat expansion

Replication Stress Induces Global Chromosome Breakage in the Fragile X Genome

Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells

Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS

Modeling Fragile X Syndrome: Characterizing Fmr1 Gene Knockout Mice across Genotype, Behavior, and Morphology